These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 12413287)

  • 1. Immunity to poliomyelitis in Victorians.
    Hogg K; Hogg G; Lester R; Uren E
    Aust N Z J Public Health; 2002 Oct; 26(5):432-6. PubMed ID: 12413287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity of supplemental doses of poliovirus vaccine for children aged 6-9 months in Moradabad, India: a community-based, randomised controlled trial.
    Estívariz CF; Jafari H; Sutter RW; John TJ; Jain V; Agarwal A; Verma H; Pallansch MA; Singh AP; Guirguis S; Awale J; Burton A; Bahl S; Chatterjee A; Aylward RB
    Lancet Infect Dis; 2012 Feb; 12(2):128-35. PubMed ID: 22071249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A seroprevalence study of poliovirus antibody against a collection of recombinant and non-recombinant poliovirus vaccine strains in the population of southern Greece.
    Pliaka V; Ruether IG; Kyriakopoulou Z; Kioussi P; Plakokefalos E; Megalou M; Pratti A; Levidiotou-Stefanou S; Markoulatos P
    Clin Microbiol Infect; 2010 Nov; 16(11):1672-5. PubMed ID: 20148919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label, phase 4, non-inferiority study.
    O'Ryan M; Bandyopadhyay AS; Villena R; Espinoza M; Novoa J; Weldon WC; Oberste MS; Self S; Borate BR; Asturias EJ; Clemens R; Orenstein W; Jimeno J; Rüttimann R; Costa Clemens SA;
    Lancet Infect Dis; 2015 Nov; 15(11):1273-82. PubMed ID: 26318714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunity against poliomyelitis in the Netherlands, assessed in 2006 to 2007: the importance of completing a vaccination series.
    van der Maas NA; Mollema L; Berbers GA; van Rooijen DM; van der Avoort HG; Conyn-Van Spaendonck MA; de Melker HE; van der Klis FR
    Euro Surveill; 2014 Feb; 19(7):20705. PubMed ID: 24576472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The German Health Interview and Examination Survey for Children and Adolescents (KiGGS): state of immunity against poliomyelitis in German children].
    Diedrich S; Schreier E
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2007; 50(5-6):771-4. PubMed ID: 17514462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroprevalence of antibody against poliovirus in inner-city preschool children. Implications for vaccination policy in the United States.
    Chen RT; Hausinger S; Dajani AS; Hanfling M; Baughman AL; Pallansch MA; Patriarca PA
    JAMA; 1996 Jun; 275(21):1639-45. PubMed ID: 8637136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humoral and intestinal immunity induced by new schedules of bivalent oral poliovirus vaccine and one or two doses of inactivated poliovirus vaccine in Latin American infants: an open-label randomised controlled trial.
    Asturias EJ; Bandyopadhyay AS; Self S; Rivera L; Saez-Llorens X; Lopez E; Melgar M; Gaensbauer JT; Weldon WC; Oberste MS; Borate BR; Gast C; Clemens R; Orenstein W; O'Ryan G M; Jimeno J; Clemens SA; Ward J; Rüttimann R;
    Lancet; 2016 Jul; 388(10040):158-69. PubMed ID: 27212429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of seroprevalence against poliovirus among Italian adolescents and adults.
    Lupi S; Stefanati A; Baldovin T; Roman A; Baldo V; Gabutti G
    Hum Vaccin Immunother; 2019; 15(3):677-682. PubMed ID: 30427738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroprevalence of poliovirus antibodies amongst children in Zaria, Northern Nigeria.
    Giwa FJ; Olayinka AT; Ogunshola FT
    Vaccine; 2012 Nov; 30(48):6759-65. PubMed ID: 23000220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity of a supplemental dose of oral versus inactivated poliovirus vaccine.
    Moriniere BJ; van Loon FP; Rhodes PH; Klein-Zabban ML; Frank-Senat B; Herrington JE; Pallansch MA; Patriarca PA
    Lancet; 1993 Jun; 341(8860):1545-50. PubMed ID: 8099637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. National serosurvey of poliovirus immunity in Australia, 1996-99.
    Gidding HF; Backhouse JL; Gilbert GL; Burgess MA
    Aust N Z J Public Health; 2005 Feb; 29(1):48-52. PubMed ID: 15782872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A national cross-sectional study for poliovirus seroprevalence in the Republic of Korea in 2012: implication for deficiency in immunity to polio among middle-aged people.
    Kim HJ; Hwang S; Lee S; Kwon Y; Park K; Park YJ; Bae GR; Lee SW; Jeong YS; Hyeon JY
    BMC Infect Dis; 2015 Mar; 15():164. PubMed ID: 25881203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccine-induced mucosal immunity to poliovirus: analysis of cohorts from an open-label, randomised controlled trial in Latin American infants.
    Wright PF; Connor RI; Wieland-Alter WF; Hoen AG; Boesch AW; Ackerman ME; Oberste MS; Gast C; Brickley EB; Asturias EJ; Rüttimann R; Bandyopadhyay AS
    Lancet Infect Dis; 2016 Dec; 16(12):1377-1384. PubMed ID: 27638357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Indicators of immunity in children vaccinated with live poliomyelitis vaccine].
    Kaplan AS; Vasilevskaia NI; Kozhevnikov IN
    Zh Mikrobiol Epidemiol Immunobiol; 1978 Jan; (1):115-7. PubMed ID: 204133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serological survey on immunity status against polioviruses in children and adolescents living in a border region, Apulia (Southern Italy).
    Tafuri S; Prato R; Martinelli D; Calvario A; Bozzi A; Labianca M; Patti A; Lopalco PL; Germinario C
    BMC Infect Dis; 2008 Oct; 8():150. PubMed ID: 18973678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poliovirus vaccines. Progress toward global poliomyelitis eradication and changing routine immunization recommendations in the United States.
    Sutter RW; Prevots DR; Cochi SL
    Pediatr Clin North Am; 2000 Apr; 47(2):287-308. PubMed ID: 10761505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect on seroprevalence of anti-poliovirus antibodies and on vaccination coverage of the implementation of a DTwP-IPV-Hib vaccination programme in a South American city.
    Nates SV; Frias M; Belfiore S; Isa MB; Martinez LC; Chuit R; Armoni J; Luxemburger C
    Epidemiol Infect; 2011 Jun; 139(6):826-35. PubMed ID: 20587121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Herd immunity against poliomyelitis in children in the Moscow Region].
    Seĭbil' VB; Malyshkina LP; Tamazian GV; Konopleva TN; Uspenskaia ES
    Vopr Virusol; 2009; 54(6):13-8. PubMed ID: 20030276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [German Health survey 1997/98: immune status against poliomyelitis].
    Diedrich S; Claus H; Thierfelder W; Bellach BM; Schreier E
    Dtsch Med Wochenschr; 2000 May; 125(19):584-8. PubMed ID: 11320716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.